Identification of central regulatory hubs in the molecular interaction network underlying cardiac fibroblast-to-myofibroblast transition
References
- Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, Driskell RR, Rosenthal N, Biernaskie J, Horsley V. Fibroblasts: Origins, definitions, and functions in health and disease. Cell. 2021;184(15):3852-72; DOI:10.1016/j.cell.2021.06.024.
- Griffin MF, Li DJ, Chen K, Parker JBL, Guo JL, Kim S, Kraft K, Downer M, Morgan AG, Kuhnert MM, Jing SL, Yao H, Valencia C, Cotterell A, Januszyk M, Gurtner GC, Chang HY, Wysocka J, Wan DC, Longaker MT. Fibroblasts of disparate developmental origins harbor anatomically variant scarring potential. Cell. 2026;189(3):783-99.e20; DOI:10.1016/j. cell.2025.12.014.
- Wnuk D, Paw M. Fibroblasts: A molecular and pathophysiological perspective. Biomedicines. 2025;13(11):2754; DOI:10.3390/biomedicines13112754.
- Frommer ML, Langridge BJ, Awad L, Jasionowska S, Denton CP, Abraham DJ, Abu-Hanna J, Butler PEM. Single-cell analysis of ADSC interactions with fibroblasts and endothelial cells in scleroderma skin. Cells. 2023;12(13):1784; DOI:10.3390/cells12131784.
- Chang Y, Cho B, Kim S, Kim J. Direct conversion of fibroblasts to osteoblasts as a novel strategy for bone regeneration in elderly individuals. Exp Mol Med. 2019;51(5):1-8; DOI:10.1038/s12276-019-0251-1
- Baum J, Duffy HS. Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol. 2011;57(4):376-9; DOI:10.1097/FJC.0b013e3182116e39.
- Pesce M, Duda GN, Forte G, Girao H, Raya A, Roca-Cusachs P, Sluijter JPG, Tscho pe C, Van Linthout S. Cardiac fibroblasts and mechanosensation in heart development, health and disease. Nat Rev Cardiol. 2023;20(5):309-24; DOI:10.1038/s41569-022-00799-2..
- Doolin MT, Smith IM, Stroka KM. Fibroblast to myofibroblast transition is enhanced by increased cell density. Mol Biol Cell. 2021;32(22):ar41; DOI:10.1091/mbc.E20-08-0536.
- Yu X, Smith S, Wang C. Reversing fibroblast-to-myofibroblast transition using surface-engineered nanoparticles to potentially ameliorate fibrotic diseases. Biomaterials. 2026;328:123829; DOI:10.1016/j. biomaterials.2025.123829.
- Tai Y, Woods EL, Dally J, Kong D, Steadman R, Moseley R, Midgley AC. Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis. Biomolecules. 2021;11(8):1095; DOI:10.3390/biom11081095.
- McAnulty RJ. Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol. 2007;39(4):666-71; DOI:10.1016/j.biocel.2006.11.005.
- Yousefi F, Shabaninejad Ż, Vakili S, Derakhshan M, Movahedpour A, Dabiri H, Ghasemi Y, Mahjoubin-Tehran M, Nikoozadeh A, Savardashtaki A, Mirzaei H, Hamblin MR. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal. 2020;18(1):87; DOI:10.1186/s12964-020-00555-4.
- Maruyama K, Imanaka-Yoshida K. The pathogenesis of cardiac fibrosis: a review of recent progress. Int J Mol Sci. 2022;23(5):2617; DOI:10.3390/ijms23052617.
- Hinderer S, Schenke-Layland K. Cardiac fibrosis – a short review of causes and therapeutic strategies. Adv Drug Deliv Rev.;146:77-82; DOI:10.1016/j.addr.2019.05.011.
- Herum KM, Lunde IG, McCulloch AD, Christensen G. The soft- and hard--heartedness of cardiac fibroblasts: mechanotransduction signaling pathways in fibrosis of the heart. J Clin Med. 2017;6(5):53; DOI:10.3390/jcm6050053.
- Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144-53; DOI:10.1038/nrendo.2015.216.
- Ashok G, Miryala SK, Saju MT, Anbarasu A, Ramaiah S. FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer. Mol Genet Genomics. 2022;297(6):1565-80; DOI:10.1007/s00438-022-01943-w.
- Mele ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56(2):225-31; DOI:10.1161/HYPERTENSIONAHA.109.148635.
- Haugen E, Gan LM, Isic A, Skommevik T, Fu M. Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Exp Clin Cardiol. 2008;13(1):19-24.
- Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB. TAŻ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000;19(24):6778-91; DOI:10.1093/emboj/19.24.6778.
- Chen J, Li Y, Du C, Wei T, Shan T, Wang L. Protein kinases in cardiovascular diseases. Chin Med J (Engl). 2022;135(5):557-70; DOI:10.1097/CM9.0000000000001870.
- Tuleta I, Frangogiannis NG. Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities. Adv Drug Deliv Rev. 2021;176:113904; DOI:10.1016/j.addr.2021.113904.
- Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol. 2007 Mar;27(2):130-43; DOI:10.1016/j. semnephrol.2007.01.006.
- Sun J, Zhou R, Liu M, Zhang D. The role of myocardial fibrosis in the diabetic cardiomyopathy. Diabetol Metab Syndr. 2025;17(1):242; DOI:10.1186/s13098-025-01783-9.
DOI: https://doi.org/10.2478/acb-2026-0004 | Journal eISSN: 2544-3577 (formerly 2080-2218)
Language: English
Page range: 30 - 39
Submitted on: Apr 29, 2026
Accepted on: Jun 15, 2026
Published on: Jul 20, 2026
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Dominika Żukowska, Paul Mozdziak, Bartosz Kempisty, Artur Bryja, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.